News Archive

Two women standing at a podium, one wearing a black and white checkered shirt, smiling as she speaks; beside them stands another woman dressed in a stylish business casual outfit with a dark brown bob.

UPMC, Pitt to Test ‘Revolutionary’ Breast Cancer Vaccine

UPMC and University of Pittsburgh researchers will test a vaccine to prevent breast cancer in what they say is a revolutionary step in the fight against the most common cancer in women. Through the clinical trial, doctors will evaluate how well the immune system of women newly diagnosed with ductal carcinoma in situ (DCIS) respond to the vaccine, which will be administered along with the standard of care for early breast cancer.

University of Pittsburgh Receives Prestigious NIH Award for Research Excellence in Ovarian Cancer

The University of Pittsburgh was awarded a five-year grant from the National Institutes of Health (NIH) to support an Ovarian Cancer Specialized Program of Research Excellence (SPORE). The Ovarian SPORE aims to improve survival for women with ovarian cancer by improving the efficacy of therapies by preventing or overcoming therapeutic resistance.

Novel Clinical Trial – First in United States – to Begin at UPMC and UPMC Hillman Cancer Center to Treat Glioblastoma with Innovative Photodynamic Therapy

A first of its kind clinical trial in the United States to treat glioblastoma will be launching in early 2024 at UPMC and the UPMC Hillman Cancer Center, which combines intraoperative photodynamic therapy (PDT) with the drug Pentalafen® and a new laser device Heliance®, both, developed by the French company, Hemerion Therapeutics®, sponsor of the clinical trial.